Aminoglycoside-induced nephrotoxicity
Clicks: 310
ID: 115973
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Star Article
30.0
/100
310 views
44 readers
AI Quality Assessment
Not analyzed
Readership in this journal
StarRanked #5 of 7 articles by views in journal of pharmacy practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Aminoglycosides are among the oldest antibiotics available to treat serious infections caused by primarily, Gram-negative bacteria. The most commonly utilized parenteral agents in this class include gentamicin, tobramycin and amikacin. Aminoglycosides are concentration-dependent, bactericidal agents …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (35 words).
Try re-searching for a better abstract.
| Reference Key |
ka2014journalaminoglycoside-induced
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wargo KA;Edwards JD;; |
| Journal | journal of pharmacy practice |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pmid:25199523
doi:10.1177/0897190014546836
kurt a wargo
jonathan d edwards
amikacin / adverse effects*
anti-bacterial agents / adverse effects*
gentamicins / adverse effects*
kidney diseases / chemically induced*
tobramycin / adverse effects*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.